Yun Chen

The Seventh Affiliated Hospital of Sun Yat-sen University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Hsiao‐Chun Huang

National Taiwan University

Michael Hsiao

Genomics Research Center, Academia Sinica

Shu-Jung Chang

National Taiwan University

Ting‐Chun Chen

National Yang Ming Chiao Tung University

Yu‐Ting Hsu

National Taiwan University

Jorge E. Galán

Yale University

Chun Chen

Fujian Medical University

Hsuan Lin

Genomics Research Center, Academia Sinica

Jean Lu

Genomics Research Center, Academia Sinica

Chun‐Yen Feng

National Taiwan University

Cooperative Institutions

National Taiwan University

National Institutes of Health

Sun Yat-sen University

The Seventh Affiliated Hospital of Sun Yat-sen University

New York Institute of Technology

Genomics Research Center, Academia Sinica

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart Lung and Blood Institute

Center for Cancer Research

Cancer Research UK

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Arginase: Mechanisms and Clinical Application in Hematologic Malignancy

Frontiers in Oncology (2022)

Zefan Du Tianwen Li Junbin Huang Yun Chen Chun Chen

Compared to normal tissues and cells, the metabolic patterns of tumor illnesses are more complex, and there are hallmarks of metabolic reprogramming in energy metabolism, lipid metabolism, and amino acid metabolism. When tumor cells are in a state of fast growth, they are susceptible to food shortage, resulting in growth suppression. Using this metabolic sensitivity of tumor cells to construct amino acid consumption therapy does not harm the function of normal cells, which is the focus of metabolic therapy research at the moment. As a non-essential amino acid, arginine is involved in numerous crucial biological processes, including the signaling system, cell proliferation, and material metabolism. Rapidly dividing tumor cells are more likely to be deficient in arginine; hence, utilizing arginase to consume arginine can suppress tumor growth. Due to the absence of arginine succinate synthase, arginine succinate lyase, and ornithine carbamoyl transferase in some blood tumors, arginases may be employed to treat blood tumors. By investigating the mechanism of arginase treatment and the mechanism of drug resistance in greater depth, arginase treatment becomes more successful in hematological cancers and a new anti-cancer agent in clinical practice.

10.3389/fonc.2022.905893

Cite

Citations (3)